Member of the Association of American Physicians
Her primary areas of investigation include Acquired immunodeficiency syndrome, Immunology, Pediatrics, Life expectancy and Family medicine. Her Acquired immunodeficiency syndrome research includes elements of Quality-adjusted life year, Surgery and Cost-effectiveness analysis. Her studies deal with areas such as Psychological intervention, Opportunistic infection and Disease as well as Surgery.
She interconnects Observational study, Internal medicine, Systematic review and Latent tuberculosis in the investigation of issues within Immunology. Her Life expectancy research is multidisciplinary, incorporating perspectives in Physical therapy, Cohort study, Cohort and Risk factor. Her Family medicine research integrates issues from Health care, Outpatient clinic, HIV diagnosis, Antiretroviral therapy and Psychiatry.
Rochelle P. Walensky focuses on Acquired immunodeficiency syndrome, Pediatrics, Immunology, Family medicine and Internal medicine. Her Acquired immunodeficiency syndrome research is multidisciplinary, relying on both Life expectancy, Gerontology and Public health. The study incorporates disciplines such as Cost–benefit analysis, Cohort and Cost-effectiveness analysis in addition to Life expectancy.
Her work in Pediatrics covers topics such as Developing country which are related to areas like Psychological intervention. Many of her studies on Immunology involve topics that are commonly interrelated, such as Intensive care medicine. Her Family medicine study also includes
Her scientific interests lie mostly in Internal medicine, Coronavirus disease 2019, Acquired immunodeficiency syndrome, Severe acute respiratory syndrome coronavirus 2 and MEDLINE. Her Internal medicine research is multidisciplinary, incorporating elements of Penicillin allergy and Antibiotics. Her studies in Coronavirus disease 2019 integrate themes in fields like Incidence, Isolation and Intensive care medicine.
Her study in Acquired immunodeficiency syndrome is interdisciplinary in nature, drawing from both Psychological intervention, Life expectancy and Regimen. The Life expectancy study combines topics in areas such as Young adult, Predictive validity, Pediatrics and Cost-effectiveness analysis. Her MEDLINE research includes themes of Cross-sectional study, Clinical trial, Health care and Family medicine.
Rochelle P. Walensky mainly focuses on Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2, MEDLINE, 2019-20 coronavirus outbreak and Pandemic. Her biological study spans a wide range of topics, including Young adult, Test, Cohort and Intensive care medicine. Her Intensive care medicine research focuses on Vaccine efficacy and how it connects with Global health.
Her MEDLINE study incorporates themes from Odds ratio, Internal medicine, Logistic regression, Clinical trial and Ethnic group. Internal medicine connects with themes related to Penicillin allergy in her study. As a part of the same scientific study, she usually deals with the 2019-20 coronavirus outbreak, concentrating on Betacoronavirus and frequently concerns with Epidemiology, Infectious Disease Contact Tracing and Health policy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Survival Benefits of AIDS Treatment in the United States
Rochelle P. Walensky;Rochelle P. Walensky;A. David Paltiel;Elena Losina;Lauren M. Mercincavage.
The Journal of Infectious Diseases (2006)
Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
A. David Paltiel;Milton C. Weinstein;April D. Kimmel;George R. Seage.
The New England Journal of Medicine (2005)
Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume.
Elena Losina;Rochelle P. Walensky;Courtenay L. Kessler;Parastu S. Emrani.
JAMA Internal Medicine (2009)
The lifetime cost of current human immunodeficiency virus care in the United States.
Bruce R. Schackman;Kelly A. Gebo;Rochelle P. Walensky;Elena Losina.
Medical Care (2006)
International AIDS Society global scientific strategy: towards an HIV cure 2016
Steven G Deeks;Sharon R Lewin;Anna Laura Ross;Jintanat Ananworanich.
Nature Medicine (2016)
Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States.
A. David Paltiel;Amy Zheng;Rochelle P. Walensky.
JAMA Network Open (2020)
Review of Human Immunodeficiency Virus Type 1-Related Opportunistic Infections in Sub-Saharan Africa
Charles B. Holmes;Elena Losina;Rochelle P. Walensky;Yazdan Yazdanpanah.
Clinical Infectious Diseases (2003)
Risk of Progression to Active Tuberculosis Following Reinfection With Mycobacterium tuberculosis
Jason R. Andrews;Farzad Noubary;Rochelle P. Walensky;Rodrigo Cerda.
Clinical Infectious Diseases (2012)
Cost-effectiveness of HIV treatment in resource-poor settings - The case of Côte d'Ivoire
Sue J. Goldie;Yazdan Yazdanpanah;Elena Losina;Milton C. Weinstein.
The New England Journal of Medicine (2006)
HIV Preexposure Prophylaxis in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes, and Cost-Effectiveness
A. David Paltiel;Kenneth A. Freedberg;Callie A. Scott;Bruce R. Schackman.
Clinical Infectious Diseases (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: